Similar Stories to Elan, Biogen Change Terms Of Tysabri Collaboration on Bing News

Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Wed, 02/06/2013 - 5:27am

Biogen Idec will take over full ownership of the multiple sclerosis treatment Tysabri from its partner Irish drugmaker Elan Corp. PLC in exchange for a $3.25 billion cash payment and royalties…

PREV NEXT
Topics:  biogen idec   tysabri   irish   elan   corp   change   
BING NEWS:
  • Biogen: A Balanced View Amidst Setbacks and Alzheimer’s Drug Potential
    Analyst Carter Gould from Barclays maintained a Hold rating on Biogen (BIIB – Research Report) and keeping the price target at $200.00.
    05/16/2024 - 11:55 am | View Link
  • Biogen, Ionis shelve ALS drug following study failure
    While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.
    05/16/2024 - 5:52 am | View Link
  • Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    Pharm.D., Head of the Neuromuscular Development Unit at Biogen. “We are deeply grateful for the contributions of the study participants and remain committed to developing treatments that can ...
    05/15/2024 - 8:30 pm | View Link
  • More
PREV NEXT

 

PREV NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News